CARAVITA, Sergio
 Distribuzione geografica
Continente #
EU - Europa 4.582
NA - Nord America 842
AS - Asia 148
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
Totale 5.582
Nazione #
IE - Irlanda 2.890
GB - Regno Unito 919
US - Stati Uniti d'America 790
IT - Italia 275
FR - Francia 272
RU - Federazione Russa 85
SE - Svezia 72
CN - Cina 56
CA - Canada 52
SG - Singapore 52
DE - Germania 25
KR - Corea 16
IN - India 14
NL - Olanda 14
FI - Finlandia 13
BG - Bulgaria 5
EU - Europa 5
ES - Italia 4
BR - Brasile 3
JP - Giappone 3
IR - Iran 2
NO - Norvegia 2
TR - Turchia 2
AT - Austria 1
BO - Bolivia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HK - Hong Kong 1
ID - Indonesia 1
IL - Israele 1
LU - Lussemburgo 1
RO - Romania 1
UA - Ucraina 1
Totale 5.582
Città #
Dublin 2.861
Southend 840
Princeton 171
Chandler 90
Moscow 77
Altamura 70
New York 63
Ashburn 58
Toronto 50
Washington 48
Fairfield 45
Wilmington 44
Dalmine 35
Ogden 27
London 25
Milan 18
Seoul 16
Bergamo 15
Amsterdam 14
Norwalk 13
Shenzhen 13
Pune 12
Guangzhou 11
Woodbridge 11
Andover 10
San Diego 10
Shanghai 10
Cambridge 9
Lappeenranta 9
Chiswick 7
Hounslow 7
Kilburn 7
Hangzhou 6
Chicago 5
Prescot 5
Singapore 5
Sofia 5
Sorbolo 5
Helsinki 4
Mountain View 4
Naples 4
New Bedfont 4
Acton 3
Anacapri 3
Ann Arbor 3
Frankfurt am Main 3
Padova 3
Piacenza 3
Ribeirão Preto 3
St Petersburg 3
Ankara 2
Atlanta 2
Beijing 2
Bremen 2
Buccheri 2
Carobbio degli Angeli 2
Catania 2
Houston 2
Islington 2
Madison 2
Madrid 2
Mugnano di Napoli 2
Ningbo 2
Rome 2
Seattle 2
Sesto Fiorentino 2
Southwark 2
Stuttgart 2
Treviglio 2
Wandsworth 2
Ancona 1
Asti 1
Boardman 1
Bologna 1
Borno 1
Bucharest 1
Bussero 1
Böblingen 1
Carrara 1
Casalmaggiore 1
Casavatore 1
Chennai 1
Chiyoda-ku 1
Cormano 1
Delhi 1
Duelmen 1
Eagle Mountain 1
Esslingen am Neckar 1
Foshan 1
Genoa 1
Greenwich 1
Haikou 1
Hamburg 1
Hitchin 1
Hong Kong 1
Jakarta 1
Jerusalem 1
La Paz 1
Lissone 1
Locate di Triulzi 1
Totale 4.837
Nome #
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? 106
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 95
Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader 94
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 94
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure with Preserved Ejection Fraction 92
Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation 90
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 89
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? 89
Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study 88
Reply to: ‘The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome’ 86
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 84
Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography 83
Proposta di una lettera di dimissione standardizzata dopo ospedalizzazione per embolia polmonare acuta 81
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes 81
Diagnostic and therapeutic models for the management of acute pulmonary embolism: An issue of local available resources 81
Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore 80
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component 79
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities 77
Exercise stress echocardiography of the pulmonary circulation and right ventricular-arterial coupling in healthy adolescents 76
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 76
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand 76
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 76
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure with Preserved Ejection Fraction? 75
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 75
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects antihypertensive combination treatment 75
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 75
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database 74
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component 74
ANMCO Position paper: Pulmonary circulation diseases and COVID-19 73
Blood pressure at high altitude: Physiology and clinical implications 72
Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps project 72
Statement ANMCO: Tromboembolismo arterioso e venoso: quali implicazioni per la pratica clinica? 70
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 70
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 70
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 70
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 70
Recent advances in multimodality imaging of the tricuspid valve 70
Decreased pulmonary vascular distensibility in adolescents conceived by in vitro fertilization 69
Stiff left atrial syndrome after low-dose radiotherapy for right breast cancer: The need for invasive hemodynamics at exercise 68
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 68
Blood pressure response in miners exposed to chronic intermittent hypoxia in Chile 68
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 67
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 67
Hyperparathyroidism in celiac disease: always secondary? 67
Pulmonary vascular function and exercise capacity in black sub-Saharan Africans 66
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 66
Pulmonary arterial hypertension 64
Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: Bias and error 64
Heart failure with preserved ejection fraction and COVID-19: which comes first, the chicken or the egg? Letter regarding the article ‘Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings’ 63
Phenotyping long COVID 63
Hemodynamic phenotyping of pulmonary hypertension in left heart failure 62
Heart failure and anemia: Effects on prognostic variables 62
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 62
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 62
Understanding mechanisms of Fontan failure: exercise haemodynamics to unmask diastolic dysfunction, again! 61
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 61
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 58
Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease 58
Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung? 57
Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies 55
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 53
Ipertensione polmonare pre-capillare o post-capillare? Il ruolo dei test provocativi in sala di emodinamica = Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab 53
CPET for Long COVID-19 52
Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis 52
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 49
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease 48
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension 47
Impact of COVID-19 lockdown on exercise capacity in PAH patients 47
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity 47
Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches 47
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 47
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 46
Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence after Electrical Cardioversion 46
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 46
Blood pressure and high altitude: physiological response and clinical management 46
Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation 46
The Conundrum of HFpEF Definition: Non-Invasive Assessment Uncertainties and Alternative Diagnostic Strategies 45
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 45
Management of anticoagulant therapy in the follow-up of pulmonary embolism in clinical practice 44
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 44
Interatrial Shunt Devices 44
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 44
Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: A case report 43
Why Do Exercise Hemodynamics Matter? 43
Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation 41
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 41
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 40
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 40
Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction 39
Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report 38
Personalized exercise prescription as a tool for hypertension management and cardiovascular prevention: Evidence and pending issues 38
Alterations of cardiovascular complexity during acute exposure to high altitude: A multiscale entropy approach 35
Cluster analysis of advanced invasive hemodynamics in heart failure with preserved ejection fraction 17
Exercise in hypoxia: a model from laboratory to on-field studies 9
Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 8
Pulmonary Hypertension Associated with Left Heart Disease 6
null 3
Totale 5.895
Categoria #
all - tutte 35.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/20221.433 79 300 213 14 120 179 90 58 83 96 154 47
2022/2023882 179 133 168 81 28 43 26 58 44 17 77 28
2023/20243.546 47 53 101 68 87 711 2.216 86 56 5 4 112
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 5.895